Scailyte
Created in 2017
- BETA
Trend leader (A+)
Existing signals make this entity one of the most dynamic startups Social networks
5,392Activities
Technologies
Entity types
Location
210, Lichtstrasse 35, 4056 Basel, Switzerland
Basel
Switzerland
Employees
Scale: 11-50
Estimated: 23
Engaged corporates
1
0 1Added in Motherbase
9 months, 1 week ago
biotech Value proposition
True precision medicine through single-cell science.
True precision medicine through single-cell science.
Scailyte, a pioneer in AI-driven biomarker discovery from single-cell omics data, has leveraged its proprietary AI platform, ScaiVision, to analyze over 60 million single-cell profiles. The company's extensive network of clinical partners and access to unique patient cohorts in oncology and auto-immunity have led to the development of multiple patent-pending biomarker signatures. Headquartered in Basel, Switzerland, Scailyte collaborates with clinical-stage biotech and pharma companies worldwide, enabling biomarker-driven drug development and paving the way for precision medicine to become a reality.
If you want to partner with, reach out to contact@scailyte.com
More information about our company, technology & services you can find on our website - https://scailyte.com
artificial intelligence, diagnostics, single-cell, medtech, biomarker, big data, clinical research, data analysis, software, and cytometry
Scailyte - True precision medicine through single-cell science
Scailyte develops cutting edge analytical pipelines to translate data into clinical applications through single-cell science.
https://scailyte.com/
